“Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer” has been added to your cart. View cart

Article: The changing role of the axillary dissection in the treatment of breast cancer

€2.42

SKU: product-article-11126 Category: General

Description
Reviews (0)

Description

The changing role of the axillary dissection in the treatment of breast cancer

Reviews

There are no reviews yet.

Be the first to review “Article: The changing role of the axillary dissection in the treatment of breast cancer”

Top

Article: The changing role of the axillary dissection in the treatment of breast cancer

Description

Reviews

Related products

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma

Article: INTRODUCTION

Article: Highlights in gynaecological cancers